During the past decade, Nippon Medical School Chiba Hokusoh Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nippon Medical School Chiba Hokusoh Hospital" #1 sponsor was "Pfizer" with 3 trials, followed by "Chugai Pharmaceutical" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored, "Associations for Establishment of Evidence in Interventions" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nippon Medical School Chiba Hokusoh Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Nippon Medical School Chiba Hokusoh Hospital" are "Alzheimer Disease" (3 trials), "Major Depressive Disorder" (2 trials), "Atrial Fibrillation" (1 trials), "Atrial Fibrillation Non-Rheumatic" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Nippon Medical School Chiba Hokusoh Hospital" in a lesser frequency.

Most popular intervention types in "Nippon Medical School Chiba Hokusoh Hospital" are "Drug" (6 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "bapineuzumab" (2 trials), "placebo" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nippon Medical School Chiba Hokusoh Hospital" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Nippon Medical School Chiba Hokusoh Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Nippon Medical School Chiba Hokusoh Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Nippon Medical School Chiba Hokusoh Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".